News | July 16, 2021
Jubilant Pharmova’s Roorkee facility placed under import alert
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
The GMP certificate is valid for three years until April 2024.
Seven manufacturers of Remdesivir have increased production capacity to 1.03 crore vials per month up from 38 lakh vials per month a month ago
The company has received a certificate of Good Manufacturing Practice compliance from the Medicines & Healthcare products Regulatory Agency (MHRA) UK
Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.
Subscribe To Our Newsletter & Stay Updated
